Table 7.
Number of continents | Total n (%) |
Recruitment status | Therapeutic purpose | Repurposed n (%) |
|||
---|---|---|---|---|---|---|---|
Active n (%) |
Completed n (%) |
Other n (%) |
Symptomatic n (%) |
DMTs n (%) |
|||
Academic centers | 21 (52.5%) | 5 (55.6%) | 8 (38.1%) | 8 (80%) | 14 (46.7%) | 7 (70%) | 19 (76%) |
Biopharma industry | 17 (42.5%) | 3 (33.3%) | 13 (61.9%) | 1 (10%) | 15 (50%) | 2 (20%) | 5 (20%) |
Public–private partnership | 2 (5%) | 1 (11.1%) | 0 | 1 (10%) | 1 (3.3%) | 1 (10%) | 1 (4%) |